Currently set to Index
Currently set to Follow
ask age2b

Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy

By AGE2B team
November 7, 2021

Main idea: The treatment of neuroinflammation by immune modulation therapy in Chemotherapy-Induced Peripheral Neuropathy may potentially result in clinical benefits in terms of preventing and improving the painful peripheral neuropathy related to chemotherapeutic agents.

Abstract: Peripheral neuropathies are characterized by nerve damage and axonal loss, and they could be classified in hereditary or acquired forms. Moreover, neuroinflammatory components have also been shown in the spinal cord with microglia and astrocytes playing an important role in CIPN development. In this review, we consider different aspects of neuro-immune interactions in several CIPN preclinical studies which suggest a critical connection between chemotherapeutic agents and neurotoxicity. Taking together a better understanding of these aspects would permit the development of possible strategies to improve the management of CIPN. Acquired peripheral neuropathies are associated with several causes, including toxic agent exposure, among which the antineoplastic compounds are responsible for the so-called Chemotherapy-Induced Peripheral Neuropathy (CIPN).

Source Frontiers

Leave a Reply

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.